Prothrombin complex concentrate administration through intraosseous access for reversal of rivaroxaban

Am J Emerg Med. 2016 Mar;34(3):685.e1-2. doi: 10.1016/j.ajem.2015.07.057. Epub 2015 Jul 29.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blood Coagulation Factors / therapeutic use*
  • Factor Xa Inhibitors / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Rivaroxaban / adverse effects*
  • Venous Thrombosis / drug therapy*

Substances

  • Blood Coagulation Factors
  • Factor Xa Inhibitors
  • prothrombin complex concentrates
  • Rivaroxaban